De Benedetto et al. identified a reduced expression of cldn-1, 4, 23, and 25 in clinically unaffected AD skin of a Northern American cohort, which could contribute to the increased accessibility of this skin to allergens and flares of atopic dermatitis lesions [12,32,33]. Here, CLDN1 is linked to atopic eczema.